Delaware District Court
Judge:Gregory B Williams
Case #: 1:25-cv-00043
Nature of Suit835 Property Rights - Patent – Abbreviated New Drug Application
Cause35:1 Patent Infringement
Case Filed:Jan 10, 2025
Last checked: Friday Jan 10, 2025 3:07 PM EST
Defendant
MSN Laboratories Pvt. Ltd.
Defendant
MSN Pharmaceuticals Inc.
Plaintiff
Acerta Pharma B.V.
Represented By
Daniel M. Silver
Mccarter & English, LLP
contact info
Alexandra M. Joyce
Mccarter & English, LLP
contact info
Plaintiff
AstraZeneca AB
Represented By
Daniel M. Silver
Mccarter & English, LLP
contact info
Alexandra M. Joyce
Mccarter & English, LLP
contact info
Plaintiff
AstraZeneca Pharmaceuticals LP
Represented By
Daniel M. Silver
Mccarter & English, LLP
contact info
Alexandra M. Joyce
Mccarter & English, LLP
contact info
Plaintiff
AstraZeneca UK Limited
Represented By
Daniel M. Silver
Mccarter & English, LLP
contact info
Alexandra M. Joyce
Mccarter & English, LLP
contact info


Docket last updated: 01/16/2025 11:59 PM EST
Wednesday, January 15, 2025
utility Case Assigned/Reassigned Wed 01/15 12:49 PM
Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb)
Related: [-]
Friday, January 10, 2025
6 6 service Summons Issued Fri 01/10 2:39 PM
Summons Issued as to MSN Laboratories Pvt. Ltd. on 1/10/2025; MSN Pharmaceuticals Inc. on 1/10/2025.(oam)
Related: [-]
Att: 1 Summons Issued
5 5 misc Disclosure Statement - Rule 7.1 Fri 01/10 2:36 PM
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for Acerta Pharma B.V., AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited filed by AstraZeneca AB, Acerta Pharma B.V., AstraZeneca UK Limited, AstraZeneca Pharmaceuticals LP. (oam)
Related: [-]
4 4 misc Patent/Trademark Report to Commissioner of Patents Fri 01/10 2:33 PM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,272,083; 11,059,829. (oam)
Related: [-]
3 3 misc ANDA Form Fri 01/10 2:30 PM
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/27/2024. Date of Expiration of Patent: See Attached. Thirty Month Stay Deadline: 5/27/2027. (oam)
Related: [-]
2 2 misc Magistrate Consent Forms Fri 01/10 2:29 PM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam)
Related: [-]
1 1 17 pgs cmp Complaint Fri 01/10 2:28 PM
COMPLAINT for ANDA PATENT INFRINGEMENT filed against MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. ( Filing fee $ 405, receipt number ADEDC-4587378.) - filed by AstraZeneca UK Limited, Acerta Pharma B.V., AstraZeneca Pharmaceuticals LP, AstraZeneca AB.(oam)
Related: [-]
Att: 1 Exhibit A&B,
Att: 2 Civil Cover Sheet